John Floberg, MD, PhD

Clinically, Dr. Floberg focuses on the treatment of genitourinary cancers. As a radiation oncologist, he collaborates with urologists, medical oncologists, radiologists, pathologists and other specialists to provide patients with the best care possible.

Michael Bassetti, MD, PhD

Dr. Bassetti is an associate professor in the Department of Human Oncology with a clinical focus on gastrointestinal cancers and research interests in MRI-guided radiation and immunotherapy. He has been developing the use of real-time MRI-guided radiation to reduce toxicity, maximize local control and improve patient outcomes. Additionally, he is involved in combining immunotherapies with anatomically targeted high-dose radiotherapy to improve the antigen specific T cell response.

Gregory Cooley, MD

Dr. Cooley is a clinical associate professor in the Department of Human Oncology (DHO). The DHO is one of the few centers in the region offering both low-dose-rate and high-dose-rate prostate brachytherapy. Two decades ago, prostate brachytherapy showed superior PSA control rates. With further advances in dosing, fractionation and MRI-based planning, results are even better.

Andrew Baschnagel, MD

Dr. Baschnagel is actively involved in translational and clinical research. I work closely with basic scientists, physicists and clinicians with the goal of fostering new ideas and translating research findings into the clinic. He has experience studying combinations of radiation and novel radiosensitizers and biomarkers of treatment response in patients and in preclinical models. His current work focuses on improving treatment of non-small cell lung cancer with a focus on brain metastases. He is actively involved at the regional and national level, and I am site PI for multiple national clinical studies here at UW.